ACTIVE

PHARMACIE VEEWEYDE CENTRE

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result120,1 k €+7,7 %over 1 year

Gross margin224,7 k €+1,5 %over 1 year

Equity540 k €+8,0 %over 1 year

Workforce1,0 ETP-16,7 %over 1 year

Identity

Source · BCE/KBO

PHARMACIE VEEWEYDE CENTRE is a Public limited company incorporated in 1999. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Anderlecht. It employs on average 1,0 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0467.246.129
Incorporation: 12/11/1999
Legal form: Public limited company
Registered office: Boulevard Aristide Briand 5
1070 Anderlecht · BruxellesSee on map
Contributed capital: 346 400,00 €
Latest accounts: 31/12/2025
Average workforce: 1,0 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation 74851Other professional, scientific and technical activities 82100Office administrative and support activities 82190Photocopying, document preparation and other specialised office support activities

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	224,7 k €	+1.5%	221,5 k €	+11.7%	198,2 k €	-9.1%	218 k €	+27.6%	170,8 k €
EBITDA	185,7 k €	+7.4%	173 k €	+9.1%	158,5 k €	-14.7%	185,8 k €	+36.6%	136 k €
Operating result	144,4 k €	+2.9%	140,4 k €	+10.0%	127,6 k €	-15.3%	150,7 k €	+42.8%	105,5 k €
Net result	120,1 k €	+7.7%	111,5 k €	+34.6%	82,9 k €	-16.2%	98,9 k €	+7.7%	91,8 k €
Balance sheet
Equity	540 k €	+8.0%	499,9 k €	+9.1%	458,3 k €	+22.1%	375,4 k €	-21.2%	476,6 k €
Total assets	1,6 M €	+15.9%	1,3 M €	+6.8%	1,3 M €	-8.9%	1,4 M €	+3.1%	1,3 M €
Cash	48,2 k €	+44.1%	33,4 k €	-42.3%	58 k €	-28.6%	81,1 k €	+534%	12,8 k €
Debts	1 M €	+20.5%	841,1 k €	+5.4%	797,6 k €	-20.5%	1 M €	+16.5%	861,6 k €
Other
Workforce	1,0 ETP	-16.7%	1,2 ETP	0.0%	1,2 ETP	+20.0%	1,0 ETP	-9.1%	1,1 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 5 ended

Active mandates

A-Z pharma

Managing director · since 31 mars 2018 · 0689.800.949

Represented by Tete Kwassigan

Active

Ended mandates

A-Z pharma

Managing director · since 31 mars 2018 · 0689.800.949

Represented by Tete Kwassigan

Ended

CHANTAL VAN DER MAEREN

Director · since 09 avril 2013 · until 09 avril 2019

Ended

ETIENNE WALLON

Managing director · since 09 avril 2013 · until 09 avril 2019

Ended

CHANTAL VAN DER MAEREN

Director

Ended

Other companies at this address

Boulevard Aristide Briand 5 1070 Anderlecht

Company	CBE no.
A-Z pharma● Active	0689.800.949

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	05/08/2026	20/08/2025	21/08/2024	29/06/2023	01/09/2022	28/06/2021
General meeting	14/04/2026	08/04/2025	09/04/2024	11/04/2023	12/04/2022	13/04/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	14/04/2026	05/08/2026	French	PDF
Abridged model	31/12/2024	08/04/2025	20/08/2025	French	PDF
Abridged model	31/12/2023	09/04/2024	21/08/2024	French	PDF
Abridged model	31/12/2022	11/04/2023	29/06/2023	French	PDF
Abridged model	31/12/2021	12/04/2022	01/09/2022	French	PDF
Abridged model	31/12/2020	13/04/2021	28/06/2021	French	PDF
Abridged model	31/12/2019	14/04/2020	30/06/2020	French	PDF
Abridged model	31/12/2018	09/04/2019	05/07/2019	French	PDF
Abridged model	31/12/2017	10/04/2018	31/08/2018	French	PDF
Abridged model	31/12/2016	11/04/2017	31/08/2017	French	PDF
Abridged model	31/12/2015	12/04/2016	23/08/2016	French	PDF
Abridged model	31/12/2014	14/04/2015	13/08/2015	French	PDF
Abridged model	31/12/2013	08/04/2014	22/08/2014	French	PDF
Abridged model	31/12/2012	09/04/2013	29/08/2013	French	PDF
Abridged model	31/12/2011	10/04/2012	30/08/2012	French	PDF
Abridged model	31/12/2010	12/04/2011	31/08/2011	French	PDF
Abridged model	31/12/2009	13/04/2010	09/08/2010	French	PDF
Abridged model	31/12/2008	14/04/2009	21/08/2009	French	PDF
Abridged model	31/12/2007	08/04/2008	01/08/2008	French	PDF
Abridged model	31/12/2006	10/04/2007	30/08/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 5 ended

Active mandates

A-Z pharma

Managing director · since 31 mars 2018 · 0689.800.949

Represented by Tete Kwassigan

Active

Ended mandates

A-Z pharma

Managing director · since 31 mars 2018 · 0689.800.949

Represented by Tete Kwassigan

Ended

CHANTAL VAN DER MAEREN

Director · since 09 avril 2013 · until 09 avril 2019

Ended

ETIENNE WALLON

Managing director · since 09 avril 2013 · until 09 avril 2019

Ended

CHANTAL VAN DER MAEREN

Director

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates13/02/2025
DENOMINATION - DEMISSIONS, NOMINATIONS
PDF
Mandates14/06/2018
DEMISSIONS, NOMINATIONS
PDF
Registered office22/12/2015
SIEGE SOCIAL
PDF
Capital / shares23/01/2014
CAPITAL, ACTIONS
PDF
Mandates02/10/2013
DEMISSIONS, NOMINATIONS
PDF
Capital / shares20/01/2012
CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates02/10/2007
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 2025120,1 k €↑
2024
Annual accounts 2024111,5 k €↑
2024
Name changePHARMACIE VEEWEYDE CENTRE
2023
Annual accounts 202382,9 k €↓
2022
Annual accounts 202298,9 k €↑
2021
Annual accounts 202191,8 k €↓
2021
Name changePHARMACIE AGALEC
2020
Annual accounts 202099,3 k €↓
2019
Annual accounts 2019116,7 k €↑
2018
Annual accounts 2018-37,6 k €↓
2017
Annual accounts 2017-33 k €↓
2016
Annual accounts 2016-24,6 k €↑
2015
Annual accounts 2015-39 k €↓
2014
Annual accounts 201413,4 k €↓
2013
Annual accounts 201347,9 k €↑
2012
Annual accounts 201221,3 k €↓
2011
Annual accounts 201160,9 k €↓
2010
Annual accounts 201077,5 k €↑
2009
Annual accounts 200954,9 k €↑
2008
Annual accounts 200844,3 k €↑
2007
Annual accounts 200736,3 k €↑
2006
Annual accounts 200630,4 k €
12/11/1999
IncorporationPublic limited company

PHARMACIE VEEWEYDE CENTRE

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline